Sleep feels good. However, researchers have found that sleep could actually change your brain chemistry, in terms of your risk of Alzheimer’s disease. That’s right. Real changes in proteins & long-term dementia risk, even what happens when you take a sleep pill in a lab.
But how? And why? That’s what we’re here to find out.
Featured Image Credit: Shutterstock.
Key takeaways
You’ll learn about:
- What happened to Alzheimer’s proteins after just one night of no sleep
- How a common insomnia drug lowered certain brain markers
- The connection between restless daily rhythms & amyloid buildup years later
- Why slow-wave sleep loss could lead to future dementia
A night of no sleep costs you
In one 2025 study, 12 healthy adults were asked to go through three sleep setups. The first was a normal night’s sleep with testing in the morning, while the second was a normal sleep night with testing later in the day. The last was a full night of staying awake.
What happened? After sleeping, the participants’ spinal fluid had lower levels of amyloid & tau, which are the proteins connected to Alzheimer’s. When they stayed awake, those proteins went up & their orexin levels jumped. This chemical is a signal of wakefulness. As for neurofilament light & GFAP, these other two markers stayed flat.
The main lesson from this experiment is that a single night of missed sleep is enough to change your brain chemistry…in the wrong way.
Blocking orexin overnight
A 2023 study tried something different. Instead of just stopping the participants from sleeping, they gave them suvorexant, a sleep drug that blocks orexin, not letting the body signal wakefulness, in doses of either 10 mg, 20 mg, or a placebo. All 38 of the participants were aged 45-65, and the experiment was double-blind.
About five hours after the higher dose, amyloid levels dropped by 10–20%. The ratio of p-tau181/tau181 fell 10–15%, while other tau sites didn’t really budge. Interestingly, the participants’ total sleep time during the stay wasn’t that different between groups.
And no, these people didn’t magically sleep longer during the hospital stay. It seems that the drug directly influenced how much amyloid & tau built up in the fluid around the brain. To recap, lower levels of these mean lower risk of Alzheimer’s.
Rest–activity fragmentation today, more amyloid years later
The Rotterdam Study was a longer experiment that involved 319 adults wearing actigraphy devices for a week. Almost eight years later, they went through amyloid PET scans.
People with more fragmented daily rhythms showed higher amyloid buildup later. These included people with many ups & downs in terms of movement and rest. The effect was stronger in people with the APOE-ε4 gene variant. This gene is a well-known risk factor for Alzheimer’s.
As such, the issue wasn’t necessarily how long they slept, but rather, whether their sleep or rest was steady or broken up.
Slow-wave sleep loss over time
Deep, slow-wave sleep is the kind of sleep that leaves you feeling restored. In the Framingham Heart Study, 346 older adults had sleep studies around five years apart. They were then followed up 17 years later.
The major finding was that every 1% yearly drop in slow-wave sleep was tied to a 27% higher chance of being diagnosed with dementia later on. Additionally, people with the APOE-ε4 gene had a more pronounced drop in slow-wave sleep. This gene puts you at a high risk for Alzheimer’s.
Those who lost the most deep sleep were the ones most likely to be diagnosed with dementia later on. This seems to suggest that deep sleep is good for your health in the long term, and not simply because it makes you less tired. It’s good for your brain.
30 studies on sleep and Alzheimer’s biomarkers
To pull all this together, researchers combined 30 studies with nearly 15,000 participants who didn’t have dementia. Overall, worse sleep quality & shorter sleep duration meant that they had higher amyloid levels on PET scans and higher plasma Aβ42.
However, the tau results were all over the place, with no clear pattern across fluid or imaging studies.
Pooling that much data made it even clearer that there is a connection between sleep and amyloid levels, especially in people who hadn’t developed dementia yet.
What these datasets measured
When you lay them side by side, you can see the different ways that sleep affects our brains:
- Spinal fluid sampling shows clear evidence of amyloid & tau changes after a single night of sleep or sleep loss.
- Drug trials suggest that blocking orexin overnight could reduce your amyloid & certain tau levels.
- Activity monitors revealed that disrupted daily rhythms predicted amyloid years later.
- Sleep lab follow-ups tied slow-wave sleep loss to actual dementia diagnoses.
- The meta-analysis connected the studies together across thousands of participants.
The general consensus
All of these studies, from lab nights to years-long follow-ups, point to the same idea. The brain clears out Alzheimer’s-related proteins better when you have deep & consistent sleep.
Just one night of lost sleep is enough to raise those proteins in your spinal fluid. Worse still, years of fragmented rest could increase your amyloid buildup & raise your dementia risks down the road. And in some cases, even a sleep medicine could change things. Who knew?
Sources: Please see here for a complete listing of all sources that were consulted in the preparation of this article.
Like our content? Be sure to follow us.
